These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 8625120
21. Immunohistochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma: relationship to histological grade. Taniai M, Tomimatsu M, Okuda H, Saito A, Obata H. J Gastroenterol Hepatol; 1993; 8(5):420-5. PubMed ID: 8105998 [Abstract] [Full Text] [Related]
22. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma. Ma S, Yang J, Li J, Song J. Tumour Biol; 2016 Jun; 37(6):7405-12. PubMed ID: 26676639 [Abstract] [Full Text] [Related]
23. Analyses of proliferating cell nuclear antigen-positive cells in hepatocellular carcinoma: comparisons with clinical findings. Nishimori H, Tsukishiro T, Nambu S, Okada K, Shimizu Y, Miyabayashi C, Higuchi K, Watanabe A. J Gastroenterol Hepatol; 1994 Jun; 9(5):425-32. PubMed ID: 7827290 [Abstract] [Full Text] [Related]
24. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH. Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120 [Abstract] [Full Text] [Related]
25. [DNA ploidy pattern in resected human hepatocellular carcinomas from the view point of biological malignant potential]. Saiki I, Une Y, Shimamura T, Uchino J. Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():135-42. PubMed ID: 8678556 [Abstract] [Full Text] [Related]
26. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma. Shiraki K, Fujikawa K, Sugimoto K, Ito T, Yamanaka T, Suzuki M, Yoneda K, Sugimoto K, Takase K, Nakano T. Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158 [Abstract] [Full Text] [Related]
27. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Maeda K, Chung YS, Onoda N, Kato Y, Nitta A, Arimoto Y, Yamada N, Kondo Y, Sowa M. Cancer; 1994 Feb 01; 73(3):528-33. PubMed ID: 7905361 [Abstract] [Full Text] [Related]
28. In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. Gramantieri L, Trerè D, Chieco P, Lacchini M, Giovannini C, Piscaglia F, Cavallari A, Bolondi L. J Hepatol; 2003 Dec 01; 39(6):997-1003. PubMed ID: 14642618 [Abstract] [Full Text] [Related]
29. The expression of c-kit and proliferating cell nuclear antigen in oval cells of rats with hepatocellular carcinoma. Fang CH, Zhang W, Zhu XY, Gong JQ, Zhang GQ. Hepatobiliary Pancreat Dis Int; 2003 Nov 01; 2(4):537-44. PubMed ID: 14627515 [Abstract] [Full Text] [Related]
30. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma. Zeng WJ, Liu GY, Xu J, Zhou XD, Zhang YE, Zhang N. World J Gastroenterol; 2002 Dec 01; 8(6):1040-4. PubMed ID: 12439921 [Abstract] [Full Text] [Related]
31. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Hiraga Y, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N. Oncology; 1998 Dec 01; 55(4):307-19. PubMed ID: 9663420 [Abstract] [Full Text] [Related]
32. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Higuchi T, Kikuchi M, Okazaki M. Cancer; 1994 May 01; 73(9):2259-67. PubMed ID: 7513245 [Abstract] [Full Text] [Related]
33. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Heegaard S, Sommer HM, Broholm H, Broendstrup O. Cancer; 1995 Nov 15; 76(10):1809-13. PubMed ID: 8625052 [Abstract] [Full Text] [Related]
34. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism. Yamaguchi S, Yachiku S, Morikawa M. J Clin Endocrinol Metab; 1997 Aug 15; 82(8):2681-8. PubMed ID: 9253354 [Abstract] [Full Text] [Related]
35. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma]. Luo HY, Wang HC, Feng DY. Hunan Yi Ke Da Xue Xue Bao; 2003 Feb 28; 28(1):17-9. PubMed ID: 12934386 [Abstract] [Full Text] [Related]
36. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen. Korkolopoulou P, Oates J, Crocker J, Edwards C. J Clin Pathol; 1993 Dec 28; 46(12):1093-6. PubMed ID: 7904273 [Abstract] [Full Text] [Related]
37. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis. Narita T, Funahashi H, Satoh Y, Takagi H. Jpn J Clin Oncol; 1993 Feb 28; 23(1):20-5. PubMed ID: 8096256 [Abstract] [Full Text] [Related]
38. [Relationship between the proliferative activity of cancer cells and microvessel density in portal vein thrombosis and transfer of hepatocellular carcinoma]. Meng CC, Chen XP, Liu AZ. Zhonghua Gan Zang Bing Za Zhi; 2002 Oct 28; 10(5):366-9. PubMed ID: 12392620 [Abstract] [Full Text] [Related]
39. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract. Lee CS. Cancer; 1996 Nov 01; 78(9):1881-7. PubMed ID: 8909306 [Abstract] [Full Text] [Related]
40. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study. Ojanguren I, Ariza A, Llatjós M, Castellà E, Mate JL, Navas-Palacios JJ. Hum Pathol; 1993 Aug 01; 24(8):905-8. PubMed ID: 7690737 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]